233 related articles for article (PubMed ID: 21472778)
21. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
22. Disordered regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase gene expression by phosphorus in X-linked hypophosphatemic (hyp) mice.
Azam N; Zhang MY; Wang X; Tenenhouse HS; Portale AA
Endocrinology; 2003 Aug; 144(8):3463-8. PubMed ID: 12865326
[TBL] [Abstract][Full Text] [Related]
23. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
24. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
Shimada T; Hasegawa H; Yamazaki Y; Muto T; Hino R; Takeuchi Y; Fujita T; Nakahara K; Fukumoto S; Yamashita T
J Bone Miner Res; 2004 Mar; 19(3):429-35. PubMed ID: 15040831
[TBL] [Abstract][Full Text] [Related]
25. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation and renal localization of 1,25-dihydroxyvitamin D3-24-hydroxylase gene expression: effects of the Hyp mutation and 1,25-dihydroxyvitamin D3.
Roy S; Tenenhouse HS
Endocrinology; 1996 Jul; 137(7):2938-46. PubMed ID: 8770917
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of renal type IIa sodium-dependent phosphate cotransporter during lipopolysaccharide-induced acute inflammation.
Ikeda S; Yamamoto H; Masuda M; Takei Y; Nakahashi O; Kozai M; Tanaka S; Nakao M; Taketani Y; Segawa H; Iwano M; Miyamoto K; Takeda E
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F744-50. PubMed ID: 24500689
[TBL] [Abstract][Full Text] [Related]
28. Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.
Paulo JA; McAllister FE; Everley RA; Beausoleil SA; Banks AS; Gygi SP
Proteomics; 2015 Jan; 15(2-3):462-73. PubMed ID: 25195567
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-23-mediated inhibition of renal phosphate transport in mice requires sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) and synergizes with parathyroid hormone.
Weinman EJ; Steplock D; Shenolikar S; Biswas R
J Biol Chem; 2011 Oct; 286(43):37216-21. PubMed ID: 21908609
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.
Orfanidou T; Malizos KN; Varitimidis S; Tsezou A
Exp Biol Med (Maywood); 2012 Mar; 237(3):241-53. PubMed ID: 22393163
[TBL] [Abstract][Full Text] [Related]
31. The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice.
Miedlich SU; Zhu ED; Sabbagh Y; Demay MB
Endocrinology; 2010 Oct; 151(10):4607-12. PubMed ID: 20685875
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro.
Syal A; Schiavi S; Chakravarty S; Dwarakanath V; Quigley R; Baum M
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F450-5. PubMed ID: 16144964
[TBL] [Abstract][Full Text] [Related]
33. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.
Carpenter KA; Davison R; Shakthivel S; Anderson KD; Ko FC; Ross RD
Bone; 2022 Jan; 154():116201. PubMed ID: 34537437
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.
Bacchetta J; Sea JL; Chun RF; Lisse TS; Wesseling-Perry K; Gales B; Adams JS; Salusky IB; Hewison M
J Bone Miner Res; 2013 Jan; 28(1):46-55. PubMed ID: 22886720
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
Nakatani T; Ohnishi M; Razzaque MS
FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304
[TBL] [Abstract][Full Text] [Related]
36. Effect of phosphate supplementation on the expression of the mutant phenotype in murine X-linked hypophosphatemic rickets.
Tenenhouse HS; Martel J; Rubin J; Harvey N
Bone; 1994; 15(6):677-83. PubMed ID: 7873297
[TBL] [Abstract][Full Text] [Related]
37. Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate.
Tenenhouse HS; Martel J; Gauthier C; Zhang MY; Portale AA
Endocrinology; 2001 Mar; 142(3):1124-9. PubMed ID: 11181527
[TBL] [Abstract][Full Text] [Related]
38. Primary cultures of renal epithelial cells from X-linked hypophosphatemic (Hyp) mice express defects in phosphate transport and vitamin D metabolism.
Bell CL; Tenenhouse HS; Scriver CR
Am J Hum Genet; 1988 Sep; 43(3):293-303. PubMed ID: 3414685
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis.
Li CH; Tang X; Wasnik S; Wang X; Zhang J; Xu Y; Lau KW; Nguyen HB; Baylink DJ
BMC Infect Dis; 2019 Dec; 19(1):1020. PubMed ID: 31791247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
